title: Counterpoint: adherence to early goal-directed therapy: does it really matter? No. Both risks and benefits require further study.
authors.affiliation: Division of Pulmonary Diseases, Critical Care, and Occupational Medicine, Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA. Gregory-a-schmidt@uiowa.edu
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Schmidt
mesh_terms: D002985:Clinical Protocols; D019983:Guideline Adherence; D006801:Humans; D018802:Patient-Centered Care / Q000458:organization & administration*; D018570:Risk Assessment; D018805:Sepsis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome